iTeos Therapeutics, Inc.
NASDAQ:ITOS
7.25 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 35 | 0 | -11.303 | 0 | 0 | 12.595 | 53.905 | 19.487 | 41.716 | 152.522 | 240.504 | 104.271 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.309 | 0.303 | 0.233 | 0.224 | 0.198 | 0 | 0.226 | 0.203 | 0.202 | 0.18 | 0.163 | 0 | 0.2 | 0.126 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 34.691 | -0.303 | -11.536 | -0.224 | -0.198 | 12.595 | 53.679 | 19.284 | 41.514 | 152.342 | 240.341 | 104.271 | -0.2 | -0.126 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.991 | 0 | 1.021 | 0 | 0 | 1 | 0.996 | 0.99 | 0.995 | 0.999 | 0.999 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 28.715 | 37.523 | 36.686 | 36.4 | 34.225 | 27.777 | 30.638 | 29.186 | 25.598 | 25.421 | 23.932 | 26.91 | 21.096 | 17.386 | 16.102 | 14.238 | 11.643 | 9.212 | 8.726 | 6.137 | 5.825 | 5.96 | 4.998 | 3.902 | 4.351 |
| General & Administrative Expenses
| 10.982 | 11.809 | 12.112 | 12.457 | 12.703 | 12.369 | 12.642 | 13.435 | 11.927 | 11.101 | 10.76 | 11.471 | 10.615 | 9.598 | 8.761 | 15.101 | 7.046 | 5.729 | 4.799 | 2.394 | 2.418 | 2.276 | 2.699 | 2.093 | 1.769 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.982 | 11.809 | 12.112 | 12.457 | 12.704 | 12.369 | 12.642 | 13.435 | 11.927 | 11.101 | 10.76 | 11.471 | 10.615 | 9.598 | 8.761 | 15.101 | 7.046 | 5.729 | 4.799 | 2.394 | 2.418 | 2.276 | 2.699 | 2.093 | 1.769 |
| Other Expenses
| 0 | 0 | 0 | 0 | 2.093 | 1.213 | 0.771 | 0.326 | 0 | -1.381 | -0.698 | -0.439 | -0.745 | 9.567 | -8.484 | 0.06 | 0.24 | -0.283 | 0.265 | 0.012 | 1.223 | 0.945 | -0.232 | -0.535 | 0.756 |
| Operating Expenses
| 40.021 | 49.332 | 48.798 | 48.857 | 46.929 | 37.243 | 42.232 | 41.436 | 37.525 | 35.141 | 33.994 | 37.942 | 30.966 | 26.027 | 23.374 | 26.519 | 13.774 | 14.62 | 10.953 | 7.264 | 6.47 | 6.289 | 6.66 | 5.162 | 5.158 |
| Operating Income
| -40.021 | -49.332 | -48.798 | -14.166 | -47.232 | -40.146 | -43.28 | -42.621 | -24.93 | 17.383 | -15.205 | 3.335 | 120.811 | 213.52 | 79.408 | -29.339 | -18.689 | -14.941 | -13.525 | -8.531 | -8.243 | -8.236 | -7.697 | -5.995 | -6.12 |
| Operating Income Ratio
| 0 | 0 | 0 | -0.405 | 0 | 3.552 | 0 | 0 | -1.979 | 0.322 | -0.78 | 0.08 | 0.792 | 0.888 | 0.762 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.508 | 12.975 | 5.683 | 8.406 | 10.428 | 11.958 | 9.858 | 9.553 | 10.578 | 5.363 | 13.219 | 5.108 | -1.278 | 10.524 | -6.995 | 2.88 | 5.155 | 0.038 | 2.837 | 1.279 | 2.996 | 2.892 | 0.805 | 0.298 | 1.718 |
| Income Before Tax
| -33.513 | -36.357 | -43.115 | -5.76 | -36.804 | -28.188 | -33.422 | -33.068 | -14.352 | 22.746 | -1.986 | 8.443 | 119.533 | 224.044 | 72.413 | -26.459 | -13.534 | -14.903 | -10.688 | -7.252 | -5.247 | -5.344 | -6.892 | -5.697 | -4.402 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -0.165 | 0 | 2.494 | 0 | 0 | -1.139 | 0.422 | -0.102 | 0.202 | 0.784 | 0.932 | 0.694 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.607 | 7.355 | 2.243 | 1.368 | 1.412 | 2.363 | -1.181 | 1.232 | 1.199 | 2.293 | -2.977 | 2.817 | 49.951 | 39.172 | 2.771 | -0.119 | 0 | 0.001 | -0.008 | -0.05 | 0 | 0.032 | 0.029 | 0.058 | 0 |
| Net Income
| -34.613 | -43.712 | -45.358 | -7.128 | -38.216 | -30.551 | -32.241 | -34.3 | -15.551 | 20.453 | 0.991 | 5.626 | 69.582 | 184.872 | 69.642 | -26.459 | -13.534 | -14.904 | -10.68 | -7.202 | -5.247 | -5.376 | -6.921 | -5.755 | -4.402 |
| Net Income Ratio
| 0 | 0 | 0 | -0.204 | 0 | 2.703 | 0 | 0 | -1.235 | 0.379 | 0.051 | 0.135 | 0.456 | 0.769 | 0.668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.8 | -1.08 | -1.05 | -0.18 | -1.07 | -0.85 | -0.9 | -0.96 | -0.44 | 0.57 | 0.026 | 0.15 | 1.82 | 5.26 | 1.98 | -0.75 | -0.39 | -0.61 | -0.44 | -0.23 | -0.17 | -0.54 | -0.7 | -0.58 | -0.44 |
| EPS Diluted
| -0.8 | -1.08 | -1.05 | -0.18 | -1.07 | -0.85 | -0.9 | -0.96 | -0.44 | 0.54 | 0.026 | 0.15 | 1.82 | 4.89 | 1.86 | -0.75 | -0.39 | -0.61 | -0.44 | -0.23 | -0.17 | -0.54 | -0.7 | -0.58 | -0.44 |
| EBITDA
| -33.682 | -47.777 | -47.693 | -12.441 | -47.232 | -30.336 | -43.28 | -42.621 | -23.63 | 22.63 | -15.205 | 8.353 | 119.459 | 224.495 | 72.444 | -26.378 | -13.408 | -14.403 | -10.861 | -7.338 | -5.31 | -5.209 | -6.502 | -5.004 | -4.451 |
| EBITDA Ratio
| 0 | 0 | 0 | -0.355 | 0 | 2.684 | 0 | 0 | -1.876 | 0.42 | -0.78 | 0.2 | 0.783 | 0.933 | 0.695 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |